Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
The Journal of Clinical Endocrinology and Metabolism
|
March 6, 2018
Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults
Nicola Napoli, Rocky Strollo, Giuseppe Defeudis, et al.
Diabetes/Metabolism Research and Reviews
|
August 26, 2018
Sclerostin is expressed in the atherosclerotic plaques of patients who undergoing carotid endarterectomy
Gaetano Leto, Luca D'Onofrio, Federica Lucantoni, et al.
Diabetes Research and Clinical Practice
|
September 24, 2020
Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I)
Ernesto Maddaloni, Luca D'Onofrio, Francesco Alessandri, et al.
Cardiovascular Diabetology
|
October 2, 2020
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)
Ernesto Maddaloni, Luca D'Onofrio, Francesco Alessandri, et al.
Diabetes/Metabolism Research and Reviews
|
March 9, 2022
Development of a clinical risk score to predict death in patients with COVID-19
Ghadeer Alhamar, Ernesto Maddaloni, Abdullah Al Shukry, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
The Journal of Clinical Endocrinology and Metabolism
|
March 6, 2018
Serum Sclerostin and Bone Turnover in Latent Autoimmune Diabetes in Adults
Nicola Napoli, Rocky Strollo, Giuseppe Defeudis, et al.
Diabetes/Metabolism Research and Reviews
|
August 26, 2018
Sclerostin is expressed in the atherosclerotic plaques of patients who undergoing carotid endarterectomy
Gaetano Leto, Luca D'Onofrio, Federica Lucantoni, et al.
Diabetes Research and Clinical Practice
|
September 24, 2020
Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I)
Ernesto Maddaloni, Luca D'Onofrio, Francesco Alessandri, et al.
Cardiovascular Diabetology
|
October 2, 2020
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)
Ernesto Maddaloni, Luca D'Onofrio, Francesco Alessandri, et al.
Diabetes/Metabolism Research and Reviews
|
March 9, 2022
Development of a clinical risk score to predict death in patients with COVID-19
Ghadeer Alhamar, Ernesto Maddaloni, Abdullah Al Shukry, et al.
Page
of 5